Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human coronavirus NL63 (HCoV-NL63) main protease, also known as 3C-like protease (3CLpro) or non-structural protein 5 (nsp5), is a vital enzyme for the replication and maturation of the HCoV-NL63 virus (UniProt: P0C6U5). HCoV-NL63 is an alphacoronavirus that causes respiratory tract illnesses, including the common cold and croup, particularly in children and immunocompromised individuals (PMID: 16254364). The protease functions as a homodimer and is responsible for cleaving the large viral polyproteins, pp1a and pp1ab, at eleven specific sites to release functional non-structural proteins required for the viral replication complex (PMID: 18417577). Because its substrate specificity—preferring a glutamine residue at the P1 position—is not shared by any known human proteases, it is considered an excellent target for selective antiviral drug development. Therapeutic candidates like GC376 and various peptidomimetics target the catalytic cysteine residue within the active site to block enzymatic activity and halt the viral life cycle (PMID: 32511330). Furthermore, the high degree of structural conservation of this protease across the Coronaviridae family makes it a key focus for the development of broad-spectrum antiviral agents.
Inhibition of the viral main protease (Mpro/3CLpro) prevents the cleavage of viral polyproteins pp1a and pp1ab into functional non-structural proteins, thereby arresting viral replication and assembly (PMID: 18417577).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human coronavirus NL63 main protease (HCoV-NL63 Mpro) (HCoV-NL63 Mpro).